A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

A hospital has performed a record number of pioneering prostate procedures in one day in a bid to help curb NHS waiting lists ...

CLEVELAND, Oh. - It’s the leading cause of cancer deaths in men 65 and older. Traditional treatment includes chemotherapy, immunotherapy and radiation. Urologist Dr. Ruben Olivares specializes in ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...

Celebrity chefs have become such cultural fixture that we get wrapped up in more than just their culinary creativity. So when a life-shaking event like a cancer diagnosis becomes a part of their story ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced patient-reported side effects compared to longer courses of radiation, according to ...

For many men with prostate cancer, weeks of daily treatments are no longer the norm. Jonathan Tward, MD, a radiation oncologist at Huntsman Cancer Institute, explains how image guidance, real-time ...

From celebrity red carpets to GP clinics, Mounjaro is everywhere. With its promise of significant appetite suppression and weight reduction, this once-weekly injection is fast becoming a popular ...

People who receive the Covid-19 vaccine this winter may experience some side effects, including serious ones that may require attention at A&E. Vaccines are offered to help protect the body against ...